{
  "meta": {
    "title": "Vascular_Diseases_Of_Retina_Part_1",
    "url": "https://brainandscalpel.vercel.app/vascular-diseases-of-retina-part-1-c5d875a9.html",
    "scrapedAt": "2025-11-30T11:18:09.776Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute iridocyclitis</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Cataract</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Age related macular degeneration </span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary open angle glaucoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which disorder is most associated with central retinal venous occlusion?</span></p>",
      "unique_key": "DT1224953",
      "question_audio": null,
      "question_video": null,
      "map_id": 1224953,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The ophthalmic disorder most strongly associated with <strong>central retinal venous occlusion (CRVO)</strong> is <strong>primary open-angle glaucoma (POAG)</strong>.</p>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Acute iridocyclitis (Option A):</strong> There is no known association between central retinal venous occlusion and acute iridocyclitis. Acute iridocyclitis is an inflammatory condition affecting the iris and ciliary body.</p>\n<p><strong>Cataract (Option B):</strong> There is no known association between central retinal venous occlusion and cataract. A cataract is a clouding of the natural lens of the eye.</p>\n<p><strong>Age related macular degeneration (Option C):</strong> There is no known association between central retinal venous occlusion and age-related macular degeneration. Age-related macular degeneration primarily affects the macula, leading to central vision loss.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Primary open-angle glaucoma (POAG)</strong> is the disorder most commonly associated with <strong>central retinal venous occlusion (CRVO)</strong>.</li>\n<li>Other conditions like acute iridocyclitis, cataract, and age-related macular degeneration do not have a known association with CRVO.</li>\n</ul>",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Anticoagulant use</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Coexisting cancer</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Pregnancy</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Female gender</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a risk factor for idiopathic central serous chorioretinopathy?</span></p>",
      "unique_key": "DT1224968",
      "question_audio": null,
      "question_video": null,
      "map_id": 1224968,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Idiopathic central serous chorioretinopathy (CSCR)</strong> has been associated with <strong>pregnancy</strong>. This condition involves fluid accumulation beneath the retina, often leading to visual distortion.</li>\n<li>Beyond pregnancy, CSCR is also associated with other systemic conditions and medications, including lupus, organ transplantation, hemodialysis, and corticosteroid use.</li>\n<li>It is important to note that CSCR is more commonly observed in men.</li>\n<li>Other significant risk factors often summarized as the \"3 S's\" are Steroid use, Stress, and Smoking.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Anticoagulant use (Option A):</strong> There is no known association between central serous chorioretinopathy and anticoagulant use.</p>\n<p><strong>Coexisting cancer (Option B):</strong> There is no known association between central serous chorioretinopathy and coexisting cancer.</p>\n<p><strong>Female gender (Option D):</strong> The disorder is more common in men, indicating that male gender is more associated with it.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Idiopathic central serous chorioretinopathy (CSCR)</strong> is associated with <strong>pregnancy</strong>.</li>\n<li>Additional associations for CSCR include lupus, organ transplantation, hemodialysis, and corticosteroid use.</li>\n<li>CSCR is <strong>more common in men</strong>.</li>\n</ul>",
      "correct_choice_id": 13,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteoarthritis</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetes insipidus</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Arterial hypertension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Branch retinal venous occlusion is most commonly associated with which systemic disease?</span></p>",
      "unique_key": "DT1224970",
      "question_audio": null,
      "question_video": null,
      "map_id": 1224970,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Branch retinal venous occlusion (BRVO)</strong> is commonly associated with <strong>systemic hypertension</strong>.</li>\n<li>BRVO occurs when a branch of the retinal vein becomes blocked, leading to hemorrhage and fluid leakage in the affected area of the retina.</li>\n<li>Other significant risk factors for BRVO include diabetes mellitus, hyperlipidemia, and primary open-angle glaucoma.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Osteoarthritis (Option A):</strong> Osteoarthritis is a degenerative joint disease and does not have a known direct association as a risk factor for branch retinal venous occlusion.</p>\n<p><strong>Hypothyroidism (Option B):</strong> Hypothyroidism is a condition where the thyroid gland does not produce enough thyroid hormones. It is not typically identified as a direct risk factor for branch retinal venous occlusion.</p>\n<p><strong>Diabetes insipidus (Option C):</strong> Diabetes insipidus is a rare disorder characterized by excessive thirst and excretion of large amounts of dilute urine. It is distinct from diabetes mellitus and is not a known risk factor for branch retinal venous occlusion.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Arterial hypertension</strong> is the most common systemic disease associated with <strong>Branch Retinal Venous Occlusion (BRVO)</strong>.</li>\n<li>Other important risk factors for BRVO include <strong>diabetes mellitus, hyperlipidemia, and primary open-angle glaucoma</strong>.</li>\n</ul>",
      "correct_choice_id": 24,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Veins develop sclerosis after occlusion</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">The retinal artery and vein share a common adventitial sheath</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Embolism</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Retinal hemorrhages result in reduced venous flow</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the presumed cause of venous obstruction in branch retinal vein occlusion?</span></p>",
      "unique_key": "DT1224971",
      "question_audio": null,
      "question_video": null,
      "map_id": 1224971,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The presumed cause of venous obstruction in <strong>Branch Retinal Vein Occlusion (BRVO)</strong> is related to the anatomical relationship between the retinal artery and vein.</li>\n<li>At points where a retinal arteriole and venule cross, they are bound together by a <strong>common adventitial sheath</strong>.</li>\n<li>Systemic hypertension can cause hardening (sclerosis) of the retinal arterioles. This sclerotic arteriole then compresses and deforms the lumen of the adjacent venule, leading to turbulent blood flow and the formation of a blood clot (thrombosis).</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Veins develop sclerosis after occlusion (Option A):</strong> While changes in the vein may occur, the primary event leading to the obstruction is typically the compression by a sclerotic artery, not the intrinsic sclerosis of the vein before the occlusion.</p>\n<p><strong>Embolism (Option C):</strong> While emboli can cause arterial occlusions (e.g., Central Retinal Artery Occlusion), they are not the typical or presumed cause of venous obstruction in BRVO, which is more commonly due to compression at arteriovenous crossings.</p>\n<p><strong>Retinal hemorrhages result in reduced venous flow (Option D):</strong> Retinal hemorrhages are a <em>consequence</em> of the venous occlusion and the resulting back pressure, not the initial cause of the reduced venous flow leading to the occlusion itself.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>The primary mechanism for venous obstruction in <strong>Branch Retinal Vein Occlusion (BRVO)</strong> involves the <strong>compression of a retinal venule by a hardened (sclerotic) arteriole</strong> at an arteriovenous crossing point.</li>\n<li>This compression is facilitated by the <strong>common adventitial sheath</strong> that binds the artery and vein together at these crossings.</li>\n<li><strong>Systemic hypertension</strong> contributes to the hardening of the arterioles, increasing the risk of this compression.</li>\n</ul>",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitreous hemorrhage with a subhyaloid </span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Tractional retinal detachment </span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Haemorrhagic component Intraretinal hemorrhages, venous beading, and intraretinal microvascular abnormalities</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Early retinal neovascularization </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following are defining characteristics of severe nonproliferative diabetic retinopathy?</span></p>",
      "unique_key": "DT1224973",
      "question_audio": null,
      "question_video": null,
      "map_id": 1224973,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The defining characteristics of <strong>severe nonproliferative diabetic retinopathy (NPDR)</strong> include <strong>intraretinal hemorrhages, venous beading, and intraretinal microvascular abnormalities (IRMA)</strong>.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250908-0e54c2ab-2f89-4a5d-b0d1-2cd4a6fc8d3e.jpg\"><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250908-1dbe2c76-8931-41a2-9f9f-9fd43a30ad5c.jpg\">\n<p><strong>Explanation of Other Options:</strong></p>\n<ul>\n<li><strong>Vitreous hemorrhage with a subhyaloid (Option A):</strong> Vitreous hemorrhage is a feature of <strong>proliferative diabetic retinopathy (PDR)</strong>, which involves the growth of new, fragile blood vessels that can bleed into the vitreous.</li>\n<li><strong>Tractional retinal detachment (Option B):</strong> Tractional retinal detachment is a feature of <strong>proliferative diabetic retinopathy (PDR)</strong>, where fibrous tissue associated with neovascularization pulls on the retina, causing it to detach.</li>\n<li><strong>Early retinal neovascularization (Option D):</strong> Retinal neovascularization (the growth of new blood vessels) is the hallmark feature of <strong>proliferative diabetic retinopathy (PDR)</strong>, indicating a more advanced and vision-threatening stage of the disease.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Severe nonproliferative diabetic retinopathy (NPDR)</strong> is characterized by <strong>intraretinal hemorrhages, venous beading, and intraretinal microvascular abnormalities (IRMA)</strong>.</li>\n<li><strong>Vitreous hemorrhage, tractional retinal detachment, and retinal neovascularization</strong> are defining features of the more advanced stage, <strong>proliferative diabetic retinopathy (PDR)</strong>.</li>\n</ul>",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetic macular edema</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Macular pigmentary disturbance </span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Traction retinal detachment</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitreous hemorrhage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most common cause of visual loss in patients with nonproliferative diabetic retinopathy?</span></p>",
      "unique_key": "DT1224974",
      "question_audio": null,
      "question_video": null,
      "map_id": 1224974,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The most common cause of visual loss in patients with <strong>nonproliferative diabetic retinopathy (NPDR)</strong> is <strong>diabetic macular edema (DME)</strong>.</li>\n<li>DME occurs when fluid and lipids leak from damaged blood vessels in the retina and accumulate in the macula, the part of the retina responsible for sharp, central vision.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Macular pigmentary disturbance (Option B):</strong> Macular pigmentary disturbance can sometimes be a manifestation or secondary change associated with macular edema, but it is not considered the primary cause of visual loss itself. The underlying edema is the direct cause of visual impairment.</p>\n<p><strong>Traction retinal detachment (Option C):</strong> Traction retinal detachment is more typically associated with <strong>proliferative diabetic retinopathy (PDR)</strong>, which involves the growth of new, fragile blood vessels that can exert traction on the retina.</p>\n<p><strong>Vitreous hemorrhage (Option D):</strong> Vitreous hemorrhage is also more typically associated with <strong>proliferative diabetic retinopathy (PDR)</strong>, occurring when fragile new blood vessels bleed into the vitreous cavity.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Diabetic macular edema (DME)</strong> is the leading cause of visual loss in <strong>nonproliferative diabetic retinopathy (NPDR)</strong>.</li>\n<li><strong>Vitreous hemorrhage and traction retinal detachment</strong> are characteristic complications of the more advanced stage, <strong>proliferative diabetic retinopathy (PDR)</strong>.</li>\n</ul>",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior chamber paracentesis</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Ocular antihypertensive therapy</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Panretinal laser photocoagulation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following interventions is the most appropriate for treating an acute central retinal artery occlusion?</span></p>",
      "unique_key": "DT1224976",
      "question_audio": null,
      "question_video": null,
      "map_id": 1224976,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>For the acute phase management of <strong>Central Retinal Artery Occlusion (CRAO)</strong>, <strong>anterior chamber paracentesis</strong> should be considered, although its universal effectiveness is not established. This procedure aims to rapidly lower intraocular pressure, potentially dislodging the embolus or improving retinal perfusion.</li>\n<li>Another proposed intervention is <strong>ocular massage</strong>, which attempts to force retrograde or antegrade displacement of emboli.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Aspirin (Option B):</strong> Aspirin is advocated as an antiplatelet therapy to lower the risk of thrombotic events, but it is not a direct treatment for acute embolic occlusions like CRAO. It is more for secondary prevention.</p>\n<p><strong>Ocular antihypertensive therapy (Option C):</strong> Ocular antihypertensive therapies are used to lower intraocular pressure, typically for glaucoma. They are not considered useful for treating CRAO, as the primary issue is arterial blockage, not elevated intraocular pressure affecting the retinal circulation.</p>\n<p><strong>Panretinal laser photocoagulation (Option D):</strong> Panretinal photocoagulation (PRP) is a laser treatment used to ablate peripheral ischemic retina, commonly for conditions like proliferative diabetic retinopathy or neovascular glaucoma. Panretinal photocoagulation is indicated to treat anterior segment neovascularization complicating central retinal venous occlusion. PRP has not shown a benefit in treating macular edema, intraretinal hemorrhage, and would not be expected to have any effect on collateral vessels</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>In the acute phase of <strong>Central Retinal Artery Occlusion (CRAO)</strong>, interventions aimed at dislodging the embolus and restoring blood flow are crucial.</li>\n<li><strong>Anterior chamber paracentesis</strong> and <strong>ocular massage</strong> are potential acute interventions.</li>\n<li><strong>Aspirin</strong> is used for secondary prevention of thrombotic events, not acute embolic CRAO.</li>\n<li><strong>Ocular antihypertensives</strong> and <strong>panretinal laser photocoagulation</strong> are not indicated for acute CRAO.</li>\n</ul>",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Rubella and rubeola </span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Varicella zoster and herpes simplex </span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Borrelia bergdorferi and Bartonella henselae</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Mycobacterium tuberculosis and Treponema pallidum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What organisms are responsible for acute retinal necrosis (ARN) and progressive outer retinal necrosis (PORN)?</span></p>",
      "unique_key": "DT1224977",
      "question_audio": null,
      "question_video": null,
      "map_id": 1224977,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The organisms most commonly responsible for <strong>acute retinal necrosis (ARN)</strong> and <strong>progressive outer retinal necrosis (PORN)</strong> are <strong>varicella-zoster virus (VZV)</strong> and <strong>herpes simplex virus (HSV)</strong>. These viruses cause severe inflammatory and necrotizing processes in the retina.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Rubella and rubeola (Option A):</strong> Rubella and rubeola viruses do not cause acute retinitis in post-natal humans.</p>\n<p><strong>Borrelia bergdorferi and Bartonella henselae (Option C):</strong> Borrelia burgdorferi is the causative organism of Lyme disease, and Bartonella henselae is the causative organism of cat-scratch disease.</p>\n<p><strong>Mycobacterium tuberculosis and Treponema pallidum (Option D):</strong> Mycobacterium tuberculosis (causing tuberculosis) and Treponema pallidum (causing syphilis) may cause retinitis and/or choroiditis. However, they are not the causative organisms of acute retinal necrosis (ARN) and progressive outer retinal necrosis (PORN).</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Varicella-zoster virus (VZV)</strong> and <strong>herpes simplex virus (HSV)</strong> are the primary pathogens responsible for <strong>acute retinal necrosis (ARN)</strong> and <strong>progressive outer retinal necrosis (PORN)</strong>.</li>\n</ul>",
      "correct_choice_id": 72,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Jaw claudication </span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Retinal pallor</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Ocular pain</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Subacute onset </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What feature found in embolic central retinal artery occlusion (CRAO) is helpful in confirming the diagnosis?</span></p>",
      "unique_key": "DT1224979",
      "question_audio": null,
      "question_video": null,
      "map_id": 1224979,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Retinal pallor</strong> is a key feature found in <strong>embolic Central Retinal Artery Occlusion (CRAO)</strong>. This pallor is often observed as a striking \"cherry-red spot\" at the fovea, which appears relatively translucent against the pale, ischemic surrounding retina.</li>\n<li>While retinal pallor is helpful in confirming a CRAO, it is important to note that it is not specific for an <em>embolic</em> CRAO, as it can be seen in other causes of CRAO as well.</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/202202496fd4138-26ca-41a2-b338-926d363a6741.png\">\n<p>Important causes of Cherry Red Spot</p>\n<ul>\n<li>CRAO/BRAO</li>\n<li>Berlin's oedema (blunt trauma)</li>\n<li>Gaucher's disease</li>\n<li>Niemann Pick's disease</li>\n<li>Tay-Sach disease</li>\n<li>Metachromatic leukodystrophy</li>\n<li>Hurler's syndrome</li>\n<li>Multiple sulfatase deficiency</li>\n<li>Hallervorden-Spatz</li>\n<li>Farber's disease</li>\n<li>Sialdosis</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Jaw claudication (Option A):</strong> Jaw claudication suggests an inflammatory cause of central artery occlusion, such as giant cell arteritis (temporal arteritis), rather than an embolic cause.</p>\n<p><strong>Ocular pain (Option C):</strong> Ocular pain is a symptom that suggests an inflammatory cause of central artery occlusion, such as giant cell arteritis, and is not typically associated with embolic CRAO.</p>\n<p><strong>Subacute onset (Option D):</strong> A subacute or intermittent onset also suggests an inflammatory cause of central artery occlusion, such as giant cell arteritis, rather than the typically sudden onset of embolic CRAO.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Retinal pallor</strong>, often presenting as a \"cherry-red spot,\" is a crucial sign in diagnosing <strong>Central Retinal Artery Occlusion (CRAO)</strong>.</li>\n<li>Symptoms like <strong>jaw claudication, ocular pain, and subacute/intermittent onset</strong> are more indicative of an <strong>inflammatory cause</strong> of CRAO, such as temporal arteritis.</li>\n<li>If an embolic cause or other confirming feature cannot be identified on initial examination, tests like CRP and/or sedimentation rate should be considered to rule out inflammatory causes.</li>\n</ul>",
      "correct_choice_id": 82,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous cidofovir </span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravitreal foscarnet</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravitreal ganciclovir</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral valganciclovir</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most-commonly administered therapy for cytomegaloviral retinitis?</span></p>",
      "unique_key": "DT1224980",
      "question_audio": null,
      "question_video": null,
      "map_id": 1224980,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Oral valganciclovir</strong> is currently the <strong>most commonly administered therapy</strong> for <strong>cytomegaloviral (CMV) retinitis</strong>. It is preferred due to its oral administration, offering convenience for patients.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Intravenous cidofovir (Option A):</strong> Intravenous cidofovir is a therapy used for CMV retinitis, but it is less commonly administered compared to oral valganciclovir.</p>\n<p><strong>Intravitreal foscarnet (Option B):</strong> Intravitreal foscarnet is a therapy used for CMV retinitis, but it is less commonly administered compared to oral valganciclovir. Its intravitreal route makes it more invasive than oral therapy.</p>\n<p><strong>Intravitreal ganciclovir (Option C):</strong> Intravitreal ganciclovir is a therapy used for CMV retinitis, but it is less commonly administered compared to oral valganciclovir. Like intravitreal foscarnet, its route of administration is more invasive.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Oral valganciclovir</strong> is the <strong>most frequently used therapy</strong> for <strong>cytomegaloviral retinitis</strong>.</li>\n</ul>",
      "correct_choice_id": 94,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Retinitis pigmentosa</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Niacin</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Cataract surgery</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Choroidal neovascularization</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most common cause of cystoid macular edema that demonstrates a fluorescein angiographic hyperfluorescent cystic (\"petaloid\") pattern?</span></p>",
      "unique_key": "DT1224981",
      "question_audio": null,
      "question_video": null,
      "map_id": 1224981,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Cystoid Macular Edema (CME)</strong> involves retinal thickening of the macula due to a disruption of the normal blood-retinal barrier, leading to leakage from perifoveal retinal capillaries and fluid accumulation primarily in the outer plexiform layer.</li>\n<li>Of the listed causes, <strong>cataract surgery</strong> is the <strong>most common cause</strong> of clinical and angiographic CME that demonstrates a hyperfluorescent cystic (\"petaloid\") pattern on fluorescein angiography. This post-surgical inflammation is a well-known phenomenon.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Retinitis pigmentosa (Option A):</strong> Retinitis pigmentosa is a rare cause of CME. While CME can occur, it's not the most common cause of the specific angiographic pattern described.</p>\n<p><strong>Niacin (Option B):</strong> CME can occur with niacin use, particularly at doses greater than 1.5g/day, causing blurry vision. However, niacin toxicity typically does not demonstrate retinal cystic hyperfluorescence on fluorescein angiography; importantly, leakage is not reported with niacin-induced CME.</p>\n<p><strong>Choroidal neovascularization (Option D):</strong> While choroidal neovascularization (CNV) may be associated with cystic retinal thickening seen on optical coherence tomography (OCT), it rarely demonstrates a hyperfluorescent cystic (\"petaloid\") pattern on fluorescein angiography. CNV typically shows different leakage patterns.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Cystoid Macular Edema (CME)</strong> is characterized by fluid accumulation in the macula, primarily in the outer plexiform layer, due to a disrupted blood-retinal barrier.</li>\n<li><strong>Cataract surgery</strong> is the <strong>most common cause</strong> of CME that exhibits a fluorescein angiographic hyperfluorescent cystic (\"petaloid\") pattern.</li>\n</ul>",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Periphlebitis retinae</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Intraretinal cyst</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">PVD</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Exudative RD</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Eales disease is</span></p>",
      "unique_key": "DT1224982",
      "question_audio": null,
      "question_video": null,
      "map_id": 1224982,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Eales disease</strong> is an <strong>idiopathic occlusive peripheral periphlebitis</strong>, characterized by inflammation of the peripheral retinal veins leading to their occlusion.\n<ul>\n<li>It is a significant cause of visual morbidity, particularly noted in <strong>young males from the Indian subcontinent</strong>. This demographic specificity is an important point often tested.</li>\n<li>The disease progresses through <strong>three overlapping stages</strong>: inflammatory, occlusive, and retinal neovascular.</li>\n<li>While its exact cause is unknown, <strong>tubercular protein hypersensitivity</strong> may be important in the etiology, though evidence remains conflicting; some patients may have tubercular vasculitis.</li>\n<li>Diagnosis is principally by <strong>clinical examination</strong>.</li>\n<li>The visual prognosis is generally good in the majority of cases.</li>\n</ul>\n</li>\n<li><strong>Symptoms:</strong>\n<ul>\n<li><strong>Floaters or sudden visual reduction</strong> due to vitreous hemorrhage are common presentations.</li>\n<li>Systemic neurological features have been reported.</li>\n<li>Mild anterior uveitis is often present.</li>\n</ul>\n</li>\n<li><strong>Fundus Signs:</strong>\n<ul>\n<li>The condition is typically <strong>bilateral</strong>, though often asymmetrical.</li>\n<li>Key findings include <strong>peripheral periphlebitis sheathing</strong>, superficial retinal hemorrhages, and sometimes cotton wool spots.</li>\n<li><strong>Pigmented chorioretinal scars</strong> may be observed.</li>\n<li>It can lead to <strong>branch retinal vein occlusion</strong>.</li>\n<li>Peripheral capillary non-perfusion, microaneurysms, tortuosity, vascular shunts, and neovascularization with recurrent vitreous hemorrhage may develop at the junction of perfused and non-perfused retina. Disc new vessels can also sometimes develop.</li>\n<li>Vitreous hemorrhage tends to be limited and absorbed over weeks, but can persist.</li>\n<li>Macular involvement with similar changes can occur but is rare; macular oedema can develop.</li>\n</ul>\n</li>\n<li><strong>Treatment:</strong>\n<ul>\n<li><strong>Steroids</strong> (periocular, systemic, topical, intravitreal) are helpful in the inflammatory stage.</li>\n<li><strong>Antitubercular treatment</strong> is advocated by some, especially in selected patients with prior tubercular infection or severe ocular inflammatory signs, often in combination with steroids, though it remains controversial.</li>\n<li><strong>Scatter photocoagulation or cryotherapy</strong> of non-perfused retina is used to reduce the neovascular stimulus.</li>\n<li><strong>Intravitreal VEGF inhibitors</strong> may be helpful, with ongoing research.</li>\n<li><strong>Vitrectomy</strong> is indicated for persistent vitreous hemorrhage, tractional detachment, and macular epiretinal membrane.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Intraretinal cyst (Option B):</strong> An intraretinal cyst is a fluid-filled cavity within the layers of the retina. While macular edema (which can have cystic changes) may occur as a complication in Eales disease, \"intraretinal cyst\" is not the primary definition or characteristic of the disease itself.</p>\n<p><strong>PVD (Posterior Vitreous Detachment) (Option C):</strong> Posterior vitreous detachment is the separation of the vitreous gel from the retina. While floaters can be a symptom in Eales disease (often due to vitreous hemorrhage), PVD is a separate anatomical event and not the defining nature of Eales disease.</p>\n<p><strong>Exudative RD (Exudative Retinal Detachment) (Option D):</strong> Exudative RD is caused by fluid leaking from the choroid into the subretinal space. While Eales disease can lead to complications such as vitreous hemorrhage and tractional retinal detachment (in advanced stages requiring vitrectomy), it is not primarily classified as an exudative retinal detachment.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Eales disease</strong> is fundamentally an <strong>idiopathic occlusive peripheral periphlebitis</strong>.</li>\n<li>It primarily affects <strong>young males from the Indian subcontinent</strong>.</li>\n<li>The disease progresses through <strong>inflammatory, occlusive, and retinal neovascular stages</strong>.</li>\n<li>Symptoms include <strong>floaters and sudden visual reduction</strong>, often from vitreous hemorrhage.</li>\n<li>Fundus signs include <strong>peripheral periphlebitis sheathing</strong> and hemorrhages.</li>\n<li>Treatment may involve <strong>steroids, antitubercular treatment, scatter photocoagulation</strong>, and vitrectomy for complications.</li>\n</ul>",
      "correct_choice_id": 111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Usg A scan</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Usg B scan</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">OCT</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">FFA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">IOC in Vitreous hemorrhage is</span></p>",
      "unique_key": "DT1224984",
      "question_audio": null,
      "question_video": null,
      "map_id": 1224984,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The <strong>Investigation of Choice (IOC)</strong> in cases of <strong>Vitreous Hemorrhage (VH)</strong>, especially when the media are opaque and prevent clear visualization of the fundus, is <strong>B-scan ultrasonography (USG B-scan)</strong>.</li>\n<li>B-scan ultrasonography uses high-frequency sound waves to produce two-dimensional images as they reflect off interfaces between acoustically distinct structures within the eye. This allows for the visualization of intraocular structures behind opaque media, such as dense vitreous hemorrhage, to identify underlying pathologies like retinal detachment.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Usg A scan (Option A):</strong> A-scan ultrasonography provides a one-dimensional display of echoes, primarily used for axial length measurements and biometric calculations (e.g., for IOL power calculation), not for visualizing the retina through opaque media.</p>\n<p><strong>OCT (Optical Coherence Tomography) (Option C):</strong> OCT provides high-resolution cross-sectional images of the retina. While excellent for detailed retinal and macular pathology, its utility is limited in the presence of significant vitreous hemorrhage because the opaque media block the light waves necessary for imaging.</p>\n<p><strong>FFA (Fundus Fluorescein Angiography) (Option D):</strong> FFA involves injecting a fluorescent dye and taking sequential photographs of the retinal vasculature. Like OCT, it requires clear media to visualize the retina and is therefore largely ineffective in the presence of dense vitreous hemorrhage.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>B-scan ultrasonography</strong> is the <strong>Investigation of Choice (IOC)</strong> for eyes with <strong>vitreous hemorrhage</strong> or other opaque media, as it allows for the assessment of the posterior segment (e.g., to rule out retinal detachment) when direct visualization is not possible.</li>\n<li>Other imaging modalities like A-scan, OCT, and FFA are limited in cases of significant vitreous hemorrhage.</li>\n</ul>",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">DR</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">HTN-R</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">CRAO</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Temporal Arteritis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female with a history of headache is sent for a fundus examination. On examination, she is found to have generalised arterial attenuation with multiple cotton wool spots and flame shaped hemorrhages in both eyes. The probable diagnosis is</span></p>",
      "unique_key": "DT1224989",
      "question_audio": null,
      "question_video": null,
      "map_id": 1224989,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The most probable diagnosis for a 30-year-old female presenting with <strong>headache, generalized arterial attenuation, multiple cotton wool spots, and flame-shaped hemorrhages in both eyes</strong> is <strong>Hypertensive Retinopathy (HTN-R)</strong>. This constellation of funduscopic findings is characteristic of ocular changes due to uncontrolled systemic hypertension.</li>\n<li><strong>Pathophysiology of Hypertensive Retinopathy:</strong>\n<ul>\n<li>The primary response of retinal arterioles to systemic hypertension is <strong>vasoconstriction</strong>, leading to generalized arterial attenuation. This response may be less marked in older individuals due to pre-existing involutional sclerosis.</li>\n<li><strong>Arteriolosclerosis</strong>, characterized by hardening and loss of elasticity of small vessel walls, is manifested by <strong>arteriovenous (AV) nipping (nicking)</strong> at crossing points, suggesting long-standing hypertension.</li>\n<li>In sustained hypertension, the inner blood-retinal barrier is disrupted, causing increased vascular permeability. This leads to the characteristic <strong>flame-shaped retinal hemorrhages</strong> and <strong>edema</strong>.</li>\n<li><strong>Cotton wool spots</strong> are also a feature, representing areas of retinal nerve fiber layer ischemia.</li>\n</ul>\n</li>\n<li><strong>Keith-Wagner-Barker Classification (Important for grading severity):</strong>\n<ul>\n<li><strong>Grade 1:</strong> Mild generalized retinal arteriolar narrowing.</li>\n<li><strong>Grade 2:</strong> Focal arteriolar narrowing and arteriovenous nipping; a 'copper wiring' appearance of arteriolar walls may be seen.</li>\n<li><strong>Grade 3:</strong> Includes Grade 2 features plus retinal hemorrhages (dot, blot, flame-shaped), exudates (which may form a 'macular star' around the fovea due to chronic retinal edema), and cotton wool spots. The patient's findings (cotton wool spots, flame-shaped hemorrhages, arterial attenuation) align well with Grade 3.</li>\n<li><strong>Grade 4:</strong> Severe Grade 3 features plus optic disc swelling, which is a marker of malignant hypertension.</li>\n</ul>\n</li>\n<li><strong>Markers of Preclinical Systemic Disease (Important for prognosis/monitoring):</strong>\n<ul>\n<li>Reduced retinal arteriolar caliber is an early pre-hypertensive sign and should prompt blood pressure monitoring.</li>\n<li>Wider venular caliber is relatively specific for impaired glucose metabolism.</li>\n<li>Low arteriolar caliber and high venular caliber are considered markers of preclinical cardiovascular disease.</li>\n<li>Increased venular tortuosity can be associated with chronic hypertension and prehypertension.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>DR (Diabetic Retinopathy) (Option A):</strong> Diabetic retinopathy primarily involves microaneurysms, dot-blot hemorrhages, hard exudates, and sometimes neovascularization. While it can cause cotton wool spots, the combination with generalized arterial attenuation and the history of headache, suggesting systemic hypertension, makes HTN-R a more precise diagnosis.</p>\n<p><strong>CRAO (Central Retinal Artery Occlusion) (Option C):</strong> CRAO typically presents with sudden, severe, painless monocular vision loss and a characteristic \"cherry-red spot\" with diffuse retinal pallor. The bilateral findings and the specific pattern of hemorrhages and cotton wool spots are not typical for CRAO.</p>\n<p><strong>Temporal Arteritis (Option D):</strong> Temporal arteritis (Giant Cell Arteritis) usually affects older patients (over 50) and can cause sudden, severe vision loss, often due to anterior ischemic optic neuropathy or CRAO. It is typically associated with systemic symptoms like jaw claudication and scalp tenderness, which are not mentioned in this 30-year-old patient. The fundus findings described are classic for HTN-R.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Hypertensive Retinopathy (HTN-R)</strong> is characterized by fundus signs such as <strong>generalized arterial attenuation, flame-shaped hemorrhages, and cotton wool spots</strong>.</li>\n<li>The presence of these features, particularly in a patient with a history suggestive of systemic issues like headaches, points to HTN-R.</li>\n<li>The <strong>Keith-Wagner-Barker Classification</strong> is used to grade the severity of hypertensive retinopathy, with the described features falling under Grade 3.</li>\n</ul>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">CRAO</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">CRVO</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Eales disease </span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Sickel cell retinopathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Splashed Tomato appearance of retina is seen in</span></p>",
      "unique_key": "DT1224990",
      "question_audio": null,
      "question_video": null,
      "map_id": 1224990,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The \"Splashed Tomato Appearance\" of the retina, also known as \"Blood and Thunder Appearance,\" is a characteristic sign seen in <strong>Central Retinal Vein Occlusion (CRVO)</strong>. This appearance is due to the <strong>extensive hemorrhages</strong> found throughout both the central and peripheral retina, resulting from the blocked venous outflow.</li>\n<li><strong>Clinical Features of Central Retinal Vein Occlusion (CRVO):</strong>\n<ul>\n<li><strong>Symptoms:</strong> Typically presents with <strong>sudden, painless loss of vision</strong>.</li>\n<li><strong>Signs:</strong>\n<ul>\n<li>Visual acuity is often significantly decreased, commonly less than 6/60.</li>\n<li>A <strong>Relative Afferent Pupillary Defect (RAPD)</strong> may be present.</li>\n<li>The anterior segment of the eye usually appears normal.</li>\n<li><strong>Fundus Changes:</strong>\n<ul>\n<li>Marked tortuosity and dilatation of the retinal veins are prominent.</li>\n<li><strong>Extensive hemorrhages</strong> across both central and peripheral retina, creating the distinctive \"Splashed Tomato\" or \"Blood and Thunder\" appearance.</li>\n<li><strong>Cotton wool spots</strong> may be present.</li>\n<li><strong>Disc edema</strong> (swelling of the optic disc).</li>\n<li><strong>Macular edema</strong> (swelling of the macula).</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/202402171262f250-f76e-43ad-a692-fb9794b8d73d.jpg\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>CRAO (Central Retinal Artery Occlusion) (Option A):</strong> CRAO typically presents with sudden, severe, painless vision loss and a pale retina with a \"cherry-red spot\" at the fovea, due to arterial blockage and ischemia, not extensive hemorrhages.</p>\n<p><strong>Eales disease (Option C):</strong> Eales disease is an idiopathic occlusive peripheral periphlebitis characterized by inflammation of peripheral retinal veins, often causing recurrent vitreous hemorrhages and neovascularization. While hemorrhages occur, the \"Splashed Tomato\" appearance is not its defining characteristic.</p>\n<p><strong>Sickle cell retinopathy (Option D):</strong> Sickle cell retinopathy can manifest with various features, including salmon-patch hemorrhages, black sunbursts, sea fans (neovascularization), and vitreous hemorrhage. However, the generalized \"Splashed Tomato\" appearance is not typical for sickle cell retinopathy; it is specific to CRVO.</p>\n<p><strong>Key Takeaways:</strong></p>\n<p>The <strong>\"Splashed Tomato Appearance\"</strong> or <strong>\"Blood and Thunder Appearance\"</strong> on fundus examination is a pathognomonic sign of <strong>Central Retinal Vein Occlusion (CRVO)</strong>.</p>\n<p>CRVO presents with <strong>sudden, painless vision loss</strong>, marked venous tortuosity and dilatation, extensive hemorrhages, cotton wool spots, disc edema, and macular edema.</p>",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">CRAO</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">CRVO</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Berlin's edema</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Niemann Pick Disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Cherry Red spot in children after trauma is seen in</span></p>",
      "unique_key": "DT1224991",
      "question_audio": null,
      "question_video": null,
      "map_id": 1224991,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The \"Cherry-Red spot\" appearance in children following trauma is characteristic of <strong>Berlin's edema</strong>, which is also known as <strong>Commotio retinae</strong>. This condition is caused by a concussion to the sensory retina, resulting in cloudy swelling. If the macula is involved, the fovea can appear as a 'cherry-red spot' due to the relative translucency of the foveola against the surrounding edematous retina.</li>\n<li><strong>Key Features of Commotio Retinae (Berlin's Edema):</strong>\n<ul>\n<li><strong>Cause:</strong> Concussion of the sensory retina due to trauma.</li>\n<li><strong>Appearance:</strong> Leads to cloudy swelling, giving the involved area a grey appearance.</li>\n<li><strong>Location:</strong> Most frequently affects the temporal fundus.</li>\n<li><strong>Macular Involvement:</strong> If the macula is involved, a 'cherry-red spot' may be seen at the fovea.</li>\n<li><strong>Associated Findings:</strong> Severe involvement may be associated with intraretinal hemorrhage that can involve the macula.</li>\n<li><strong>Prognosis:</strong> In mild cases, the prognosis is good, with spontaneous resolution typically within around 6 weeks.</li>\n<li><strong>Sequelae:</strong> More severe commotio retinae may lead to complications such as progressive pigmentary degeneration and macular hole formation.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>CRAO (Central Retinal Artery Occlusion) (Option A):</strong> CRAO also causes a cherry-red spot, but it is typically due to arterial blockage leading to retinal ischemia, not direct trauma, and usually presents with sudden, profound vision loss. While rare, traumatic CRAO is different from Commotio retinae.</p>\n<p><strong>CRVO (Central Retinal Vein Occlusion) (Option B):</strong> CRVO presents with extensive retinal hemorrhages (\"splashed tomato\" or \"blood and thunder\" appearance), venous tortuosity, and optic disc edema, not a cherry-red spot in response to trauma.</p>\n<p><strong>Niemann Pick Disease (Option D):</strong> Niemann-Pick disease is a group of inherited metabolic disorders that can cause a cherry-red spot due to lipid accumulation in retinal ganglion cells. However, this is a systemic metabolic disorder, not an acute traumatic injury.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>A <strong>cherry-red spot in children after trauma</strong> is a classic sign of <strong>Berlin's edema (Commotio retinae)</strong>.</li>\n<li>Commotio retinae is a result of <strong>retinal concussion</strong>.</li>\n<li>While a cherry-red spot can be seen in other conditions like CRAO (ischemic) and Niemann-Pick disease (metabolic), its occurrence <strong>after trauma</strong> in children points specifically to Berlin's edema.</li>\n</ul>",
      "correct_choice_id": 153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetic Retinopathy </span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Retinitis Pigmentosa</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Eales disease</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">CNVM</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Hard exudates are seen in all except</span></p>",
      "unique_key": "DT1224994",
      "question_audio": null,
      "question_video": null,
      "map_id": 1224994,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Hard exudates</strong> are composed of lipoproteins that leak from damaged retinal blood vessels due to endothelial damage. They appear as yellowish, waxy deposits in the retina.</li>\n<li>Hard exudates are seen in a variety of conditions, including <strong>Diabetic Retinopathy (DR)</strong>, <strong>Eales disease</strong>, and <strong>Choroidal Neovascular Membrane (CNVM)</strong>.</li>\n<li><strong>Retinitis Pigmentosa (RP)</strong>, however, is primarily a group of inherited retinal degenerations characterized by progressive loss of photoreceptors and retinal pigment epithelium (RPE), leading to night blindness and peripheral vision loss. Hard exudates are <strong>not a typical or defining feature</strong> of Retinitis Pigmentosa.</li>\n<li><strong>Conditions in which Hard Exudates are Seen: </strong>\n<ul>\n<li>Diabetes Mellitus (DM), especially in Diabetic Macular Edema.</li>\n<li>Hypertension (HTN), where they can form a 'macular star'.</li>\n<li>Retinal Artery Macroaneurysm.</li>\n<li>Retinal Vascular Occlusions, such as Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO).</li>\n<li>Coats disease.</li>\n<li>Radiation Retinopathy.</li>\n<li>Capillary Hemangioma of the Retina (associated with Von Hippel-Lindau disease).</li>\n<li>Choroidal Neovascular Membrane (CNVM).</li>\n<li>Neuroretinitis (where they can also form a 'macular star').</li>\n<li>Eales disease.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Diabetic Retinopathy (Option A):</strong> Hard exudates are a common feature of diabetic retinopathy, particularly in diabetic macular edema, where they result from chronic leakage from retinal vessels.</p>\n<p><strong>Eales disease (Option C):</strong> Eales disease is an idiopathic occlusive peripheral periphlebitis that can lead to vascular leakage and, consequently, hard exudates.</p>\n<p><strong>CNVM (Choroidal Neovascular Membrane) (Option D):</strong> CNVM involves the growth of abnormal new blood vessels from the choroid into the subretinal space. These leaky vessels can cause exudation, including hard exudates.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Hard exudates</strong> are a sign of <strong>lipoprotein leakage from damaged retinal blood vessels</strong>.</li>\n<li>They are commonly seen in various vascular and exudative retinal conditions, including <strong>Diabetic Retinopathy, Hypertensive Retinopathy, Retinal Vascular Occlusions, Coats disease, CNVM, and Eales disease</strong>.</li>\n<li><strong>Retinitis Pigmentosa is the exception</strong> among the choices, as hard exudates are not a characteristic feature of this degenerative retinal disorder.</li>\n</ul>",
      "correct_choice_id": 162,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Retinal break</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetic macular edema</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitreomacular traction </span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Exudative RD </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Ocriplasmin is a recombinant protease used to treat</span></p>",
      "unique_key": "DT1224995",
      "question_audio": null,
      "question_video": null,
      "map_id": 1224995,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Ocriplasmin</strong> is a recombinant protease, a recombinant form of human plasmin, primarily used for the treatment of <strong>Vitreomacular Traction (VMT)</strong>. This therapy aims to induce pharmacological vitreolysis, thereby releasing the vitreous traction on the macula.</li>\n<li>Ocriplasmin has demonstrated success in releasing VMT in over 25% of treated eyes. It may also aid in closing macular holes when VMT is present, showing a higher success rate (40%) compared to placebo (10%).</li>\n<li>While effective, the results with ocriplasmin are generally considered inferior to those achieved with vitrectomy, which is a surgical intervention.</li>\n<li>Better outcomes with ocriplasmin are observed in cases with <strong>smaller areas of VMT</strong> and <strong>smaller macular holes</strong>.</li>\n<li>The presence of an <strong>epiretinal membrane (ERM)</strong> is a poorer prognostic indicator for ocriplasmin treatment.</li>\n<li>A rare but reported side effect is diffuse retinal dysfunction, which can include substantially decreased visual acuity, though the exact mechanism for this is uncertain.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Retinal break (Option A):</strong> Retinal breaks (like tears or holes) are typically treated with laser photocoagulation or cryopexy to create an adhesion and prevent retinal detachment. Ocriplasmin is not indicated for the direct treatment of retinal breaks.</p>\n<p><strong>Diabetic macular edema (Option B):</strong> Diabetic macular edema (DME) is primarily treated with anti-VEGF injections, steroids, or laser photocoagulation. Ocriplasmin does not have an approved indication for DME.</p>\n<p><strong>Exudative RD (Exudative Retinal Detachment) (Option D):</strong> Exudative retinal detachment is caused by fluid leakage from the choroid and is treated by addressing the underlying cause (e.g., inflammation, tumor) or with steroids/immunosuppressants. Ocriplasmin is not a treatment for exudative RD.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Ocriplasmin</strong> is a pharmacological agent specifically used for <strong>Vitreomacular Traction (VMT)</strong>, aiming to release vitreous traction.</li>\n<li>It can also help in closing <strong>smaller macular holes</strong> associated with VMT.</li>\n<li>Surgical intervention (vitrectomy) generally yields superior results for VMT, and ocriplasmin outcomes are better for smaller VMT/macular holes and are negatively impacted by the presence of an ERM.</li>\n</ul>",
      "correct_choice_id": 173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Chloroquine</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Dapsone</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Rifampicin</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Ethambutol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Bulls eye maculopathy is seen in toxicity of</span></p>",
      "unique_key": "DT1224996",
      "question_audio": null,
      "question_video": null,
      "map_id": 1224996,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Bulls eye maculopathy</strong> is a characteristic pattern of macular degeneration that can be seen in the toxicity of <strong>Chloroquine</strong>.</li>\n<li><strong>Causes of Bulls Eye Maculopathy:</strong>\n<ul>\n<li><strong>In adults:</strong>\n<ul>\n<li>Chloroquine maculopathy</li>\n<li>Advanced Stargardt disease</li>\n<li>Cone and cone-rod dystrophy</li>\n<li>Fenestrated sheen macular dystrophy</li>\n<li>Benign concentric annular macular dystrophy</li>\n<li>Clofazimine retinopathy</li>\n</ul>\n</li>\n<li><strong>In children:</strong>\n<ul>\n<li>Bardet-Biedl syndrome</li>\n<li>Hallervorden-Spatz syndrome</li>\n<li>Leber congenital amaurosis</li>\n<li>Lipofuscinosis</li>\n<li>Autosomal dominant cerebellar ataxia</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20240217bc3d24b1-d87d-479a-a889-9a9a2271dfff.jpg\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Dapsone (Option B):</strong> Dapsone is not a known cause of Bulls eye maculopathy.</p>\n<p><strong>Rifampicin (Option C):</strong> Rifampicin is not a known cause of Bulls eye maculopathy.</p>\n<p><strong>Ethambutol (Option D):</strong> Ethambutol is not associated with Bulls eye maculopathy; it is primarily known to cause optic neuropathy, affecting color vision and visual acuity.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Bulls eye maculopathy</strong> is a specific macular pattern associated with various conditions, prominently <strong>chloroquine toxicity</strong> in adults.</li>\n</ul>",
      "correct_choice_id": 181,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertension</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetes</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Bacterial Endocarditis</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">CRAO</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Roths spots are seen MC in</span></p>",
      "unique_key": "DT1224997",
      "question_audio": null,
      "question_video": null,
      "map_id": 1224997,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Roth spots</strong> are retinal hemorrhages characterized by white centers, where the whitish element is thought to be composed of coagulated fibrin in most cases. Among the given options, Roth spots are classically associated with <strong>subacute bacterial endocarditis</strong>.</li>\n<li><strong>Conditions in which Roth Spots are Seen:</strong>\n<ul>\n<li>Acute leukemias.</li>\n<li>Bacteraemia (classically subacute bacterial endocarditis).</li>\n<li>Diabetes</li>\n<li>Hypertension</li>\n<li>Anemia</li>\n</ul>\n</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20240217b0f2ff53-1ef1-4c49-a587-ceffebe24be1.jpg\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Hypertension (Option A):</strong> While Roth spots can be seen in hypertension, it is not the <em>most common</em> or classic association among the choices provided, with bacterial endocarditis being the classical example.</p>\n<p><strong>Diabetes (Option B):</strong> Roth spots can occur in diabetes, but similar to hypertension, it is not the <em>most common</em> or classical association compared to bacterial endocarditis.</p>\n<p><strong>CRAO (Central Retinal Artery Occlusion) (Option D):</strong> CRAO is characterized by sudden, severe vision loss, retinal pallor, and a \"cherry-red spot\" at the macula due to arterial occlusion. Roth spots are not a typical feature of CRAO.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Roth spots</strong> are retinal hemorrhages with white centers.</li>\n<li>They are <strong>classically associated with subacute bacterial endocarditis</strong>.</li>\n<li>Other conditions where Roth spots can be observed include acute leukemias, other forms of bacteraemia, diabetes, hypertension, and anemia.</li>\n</ul>",
      "correct_choice_id": 193,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetes</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Head trauma</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">RA</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Wilson's Disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Purtscher's retinopathy is associated with</span></p>",
      "unique_key": "DT1224998",
      "question_audio": null,
      "question_video": null,
      "map_id": 1224998,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Purtscher's retinopathy</strong> is a condition associated with various systemic causes, including <strong>head and chest trauma</strong>. It involves the blockage of retinal capillaries by emboli, leading to the characteristic presentation of multiple hemorrhages and cotton wool spots throughout the retina.</li>\n<li><strong>Causes of Purtscher's Retinopathy:</strong>\n<ul>\n<li>Acute pancreatitis.</li>\n<li><strong>Head and chest trauma</strong>.</li>\n<li>Thrombotic thrombocytopenic purpura (TTP).</li>\n<li>Fat embolism.</li>\n<li>Chronic renal failure.</li>\n<li>Amniotic fluid embolism.</li>\n<li>Systemic lupus erythematosus (SLE).</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Diabetes (Option A):</strong> While diabetes can cause various retinal complications (diabetic retinopathy), it is not a direct cause of Purtscher's retinopathy.</p>\n<p><strong>RA (Rheumatoid Arthritis) (Option C):</strong> Rheumatoid Arthritis is an autoimmune disease primarily affecting joints and is not listed as a cause of Purtscher's retinopathy.</p>\n<p><strong>Wilson's Disease (Option D):</strong> Wilson's disease is a genetic disorder of copper metabolism. It is not associated with Purtscher's retinopathy.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Purtscher's retinopathy</strong> is characterized by retinal capillary blockage due to emboli, resulting in hemorrhages and cotton wool spots.</li>\n<li>It is notably associated with <strong>trauma (head and chest)</strong>, as well as several systemic conditions including acute pancreatitis, TTP, fat embolism, chronic renal failure, amniotic fluid embolism, SLE, and scleroderma.</li>\n</ul>",
      "correct_choice_id": 202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">CRVO</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">BRVO</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">CRAO</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">DR</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Cattle Track Sign is seen in</span></p>",
      "unique_key": "DT1224999",
      "question_audio": null,
      "question_video": null,
      "map_id": 1224999,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The \"Cattle Track Sign,\" also known as segmentation or box-carring of blood flow, is a characteristic finding in <strong>Central Retinal Artery Occlusion (CRAO)</strong>. This appearance results from the severe slowing or cessation of blood flow in the retinal arteries, causing the blood column to break into segments.</li>\n<li><strong>Clinical Features of Central Retinal Artery Occlusion (CRAO):</strong>\n<ul>\n<li><strong>Symptoms:</strong> Typically presents with <strong>sudden, profound loss of vision</strong>, which is usually painless, except in cases of Giant Cell Arteritis (GCA).</li>\n<li><strong>Visual Acuity:</strong> Severely reduced, unless a cilioretinal artery preserves central vision. Absence of light perception may indicate GCA or ophthalmic artery occlusion. The prognosis is generally poor unless recovery occurs within the first few hours.</li>\n<li><strong>Pupillary Defect:</strong> A profound, sometimes total, <strong>Relative Afferent Pupillary Defect (RAPD)</strong> (amaurotic pupil) is common.</li>\n<li><strong>Fundus Changes:</strong>\n<ul>\n<li>Shows similar changes to Branch Retinal Artery Occlusion (BRAO) but involves all retinal quadrants.</li>\n<li>The classic <strong>'cherry-red spot' appearance</strong> is seen at the fovea, where the orange reflex from the intact choroid stands out against the surrounding pale, edematous retina.</li>\n<li>The peripapillary retina may appear especially swollen and opaque.</li>\n<li>Occasional small hemorrhages are not unusual.</li>\n<li>Emboli are visible in about 20% of cases.</li>\n<li>Retinal edema may take several hours to develop, and initial signs can be subtle.</li>\n<li>Over days to weeks, retinal cloudiness and the 'cherry-red spot' gradually disappear, though arteries remain attenuated.</li>\n<li>Later signs include optic atrophy, vessel sheathing, and patchy inner retinal atrophy and RPE changes.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20240217ca12a0d5-b278-4a69-85b7-cd7d8e8f72b6.jpg\"></li>\n</ul>\n</li>\n<li><strong>Complications:</strong>\n<ul>\n<li>Around 2% of eyes with CRAO may develop retinal or disc neovascularization.</li>\n<li><strong>Rubeosis iridis</strong> (neovascularization of the iris) may occur in up to 1 in 5 eyes, typically earlier than in CRVO (4-5 weeks vs. 3 months). Very poor vision with rubeosis may indicate ophthalmic artery occlusion.</li>\n</ul>\n</li>\n<li><strong>Diagnostic Aids:</strong>\n<ul>\n<li><strong>OCT</strong> may show a highly reflective embolic plaque within the superficial optic nerve head.</li>\n<li><strong>Fluorescein Angiography (FA)</strong> shows a variable delay in arterial filling and masking of background choroidal fluorescence by retinal edema. A patent cilioretinal artery will fill during the early phase.</li>\n<li><strong>Electroretinography</strong> can be helpful to confirm diagnosis, particularly to distinguish from optic nerve disease when signs are subtle; a diminished b-wave is present.</li>\n</ul>\n</li>\n<li><strong>Management:</strong>\n<ul>\n<li>Patients should be reviewed by an ophthalmologist after 3-4 weeks and then monthly to detect incipient neovascularization.</li>\n<li>If neovascularization occurs, Panretinal Photocoagulation (PRP) should be performed, and intravitreal VEGF inhibitors might be considered.</li>\n<li>Appropriate systemic management is critical.</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>CRVO (Central Retinal Vein Occlusion) (Option A):</strong> CRVO is characterized by extensive retinal hemorrhages (\"splashed tomato\" or \"blood and thunder\" appearance), marked venous tortuosity and dilatation, and cotton wool spots, due to venous outflow obstruction. It does not typically show the \"cattle track\" sign.</p>\n<p><strong>BRVO (Branch Retinal Vein Occlusion) (Option B):</strong> BRVO involves a localized area of retinal hemorrhage, edema, and cotton wool spots in the distribution of the occluded branch vein. It does not typically present with the \"cattle track\" sign, which is indicative of severe arterial flow compromise.</p>\n<p><strong>DR (Diabetic Retinopathy) (Option D):</strong> Diabetic retinopathy involves microaneurysms, hemorrhages, exudates, and sometimes neovascularization. It does not typically present with the \"cattle track\" sign, which is specific to severe arterial occlusion.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>The <strong>\"Cattle Track Sign\"</strong> (segmentation or box-carring of blood flow) is a distinctive feature of <strong>Central Retinal Artery Occlusion (CRAO)</strong>, indicating severe arterial blood flow compromise.</li>\n<li>CRAO is an ophthalmic emergency presenting with <strong>sudden, profound, painless vision loss</strong> and a <strong>'cherry-red spot'</strong> on fundus examination.</li>\n<li>Systemic evaluation is crucial to identify the source of emboli or underlying inflammatory conditions like GCA.</li>\n</ul>",
      "correct_choice_id": 213,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">100 Day glaucoma</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">20 Day glaucoma</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">70 Day glaucoma</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">80 Day glaucoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Neovascular Glaucoma in CRVO is also called as</span></p>",
      "unique_key": "DT1225000",
      "question_audio": null,
      "question_video": null,
      "map_id": 1225000,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Neovascular glaucoma (NVG)</strong> that develops as a complication of Central Retinal Vein Occlusion (CRVO) is commonly referred to as <strong>\"100-day glaucoma\"</strong>.</li>\n<li>This term arises because <strong>rubeosis iridis (neovascularization of the iris, or NVI)</strong>, which often precedes NVG, typically develops in about 50% of affected eyes usually between 2 and 4 months after the CRVO event, approximately 100 days.</li>\n<li>The presence of NVI indicates a high risk of subsequent neovascular glaucoma.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>20 Day glaucoma (Option B):</strong> This term is not a recognized common name for neovascular glaucoma in CRVO.</p>\n<p><strong>70 Day glaucoma (Option C):</strong> This term is not a recognized common name for neovascular glaucoma in CRVO.</p>\n<p><strong>80 Day glaucoma (Option D):</strong> This term is not a recognized common name for neovascular glaucoma in CRVO.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Neovascular glaucoma (NVG) secondary to Central Retinal Vein Occlusion (CRVO)</strong> is famously known as <strong>\"100-day glaucoma\"</strong>.</li>\n</ul>",
      "correct_choice_id": 221,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Inferonasal </span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Superotemporal</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Inferotemporal</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Superonasal</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Where is the visual field loss in this ocular condition?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/2024021701d632ab-1b3d-4552-8f3c-438b89841af9.jpg\"></span></p>",
      "unique_key": "DT1225001",
      "question_audio": null,
      "question_video": null,
      "map_id": 1225001,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The provided image indicates a <strong>right-sided superotemporal branch retinal vein occlusion (BRVO)</strong>.</li>\n<li>The rule of visual field defects states that the <strong>visual field loss will occur in the opposite clock hour of the retinal defect</strong>. Therefore, for a superotemporal retinal occlusion, the corresponding visual field loss will be in the <strong>inferonasal</strong>quadrant.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Superotemporal (Option B):</strong> A superotemporal visual field loss would correspond to an inferonasal retinal lesion, which is opposite to the given retinal condition.</p>\n<p><strong>Inferotemporal (Option C):</strong> An inferotemporal visual field loss would correspond to a superonasal retinal lesion.</p>\n<p><strong>Superonasal (Option D):</strong> A superonasal visual field loss would correspond to an inferotemporal retinal lesion.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>In retinal conditions causing visual field defects, the location of the <strong>visual field loss is contralateral to the location of the retinal lesion</strong> (i.e., opposite in terms of superior/inferior and temporal/nasal quadrants).</li>\n<li>For a <strong>superotemporal BRVO</strong>, the expected visual field loss is <strong>inferonasal</strong>.</li>\n</ul>",
      "correct_choice_id": 231,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">PRP</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Laser iridotomy</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">PRP plus IOP control plus intravitreal anti VEGF</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti vegf plus control IOP by doing Trabeculectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Best treatment for this condition in a patient of PDR is<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/202402172e34322b-05dd-4010-8d7c-11fa946c1d5b.jpg\"></span></p>",
      "unique_key": "DT1225002",
      "question_audio": null,
      "question_video": null,
      "map_id": 1225002,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The condition in the image is <strong>Neovascularization of the Iris (NVI)</strong>, also known as <strong>rubeosis iridis</strong>, which is the proliferation of abnormal blood vessels on the surface of the iris. In a patient with Proliferative Diabetic Retinopathy (PDR), NVI develops due to widespread retinal ischemia. The <strong>best treatment</strong> for NVI in this context is a comprehensive strategy involving <strong>Pan-Retinal Photocoagulation (PRP), intraocular pressure (IOP) control, and intravitreal anti-VEGF injections</strong>. This combination addresses the underlying ischemia, rapidly suppresses new vessel growth, and manages the associated glaucoma.</li>\n<li><strong>Characteristics and Causes of NVI:</strong>\n<ul>\n<li>NVI is defined as blood vessel proliferation along the surface of the iris.</li>\n<li>It is most commonly caused by <strong>diabetic retinopathy (DR)</strong> and central retinal venous occlusion (CRVO).</li>\n</ul>\n</li>\n<li><strong>Complications of NVI:</strong>\n<ul>\n<li><strong>Corneal decompensation</strong> due to prolonged elevation of IOP.</li>\n<li><strong>Ectropion uvea</strong> due to contracture of the fibrovascular membrane over the surface of the iris and angle of the anterior chamber.</li>\n<li><strong>Loss of vision</strong> from retinal ischemia or glaucomatous optic neuropathy.</li>\n</ul>\n</li>\n<li><strong>Treatment Components for NVI and Associated Retinal Ischemia:</strong>\n<ul>\n<li><strong>Pan-Retinal Photocoagulation (PRP):</strong> This targets the underlying retinal ischemia, reducing the stimulus for neovascularization. While it does not immediately reduce neovascularization, it provides a longer-lasting treatment effect.</li>\n<li><strong>Intravitreal Anti-VEGF Injections:</strong> These provide a rapid, albeit temporary, reduction in neovascularization by blocking Vascular Endothelial Growth Factor (VEGF), a key driver of new vessel formation.</li>\n<li><strong>Combination Therapy:</strong> A combination of PRP and anti-VEGF injections is often given initially to leverage the rapid effect of anti-VEGF with the more sustained effect of PRP.</li>\n<li><strong>IOP Control:</strong> Crucial for managing or preventing neovascular glaucoma, which is a severe complication where the new vessels obstruct the aqueous outflow pathway, leading to high IOP.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>PRP (Option A):</strong> While PRP is a fundamental part of the treatment, it is often insufficient alone, especially for rapid control of neovascularization and associated acute IOP spikes, which benefit from immediate anti-VEGF action and direct IOP management.</p>\n<p><strong>Laser iridotomy (Option B):</strong> Laser iridotomy is used to create an opening in the iris to treat pupillary block glaucoma. It is not an effective treatment for neovascular glaucoma, where the angle is occluded by a fibrovascular membrane.</p>\n<p><strong>Anti-VEGF plus control IOP by doing Trabeculectomy (Option D):</strong> Anti-VEGF and IOP control are essential. However, trabeculectomy is a surgical procedure typically considered when medical and laser treatments (like PRP) fail to control IOP, and often only after active neovascularization has been suppressed. It's not usually the initial combined strategy for managing the <em>condition itself</em> in PDR.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Neovascularization of the iris (NVI)</strong>, or rubeosis iridis, is a severe complication most commonly associated with <strong>Diabetic Retinopathy (DR)</strong> and Central Retinal Vein Occlusion (CRVO).</li>\n</ul>\n<p>The <strong>optimal treatment strategy</strong> for NVI in PDR involves a multifaceted approach: <strong>Pan-Retinal Photocoagulation (PRP)</strong>, <strong>intravitreal anti-VEGF injections</strong>, and diligent <strong>intraocular pressure (IOP) control</strong> to prevent or manage neovascular glaucoma.</p>",
      "correct_choice_id": 243,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">Flame shaped hemorhage</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">Dot blot hemorhage</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">Cotton wool spot</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">Microaneurysm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Name the lesion seen in a 55-year-old hypertensive diabetic.<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20240217add273b4-a1a0-457f-b0d8-246a3d85a0d0.jpg\"></span></p>",
      "unique_key": "DT1225003",
      "question_audio": null,
      "question_video": null,
      "map_id": 1225003,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The lesions prominently seen in the provided image, near the optic disc and scattered across the posterior pole, are elongated, superficial red streaks, which are characteristic of <strong>flame-shaped hemorrhages</strong>. These hemorrhages are typically found in the posterior pole, appear diffuse, and usually resolve within approximately 6 to 12 weeks. They primarily occur in diseases affecting the <strong>superficial retinal capillary plexus</strong>, particularly those secondary to arterial diseases such as <strong>hypertension</strong> and blood dyscrasias. Given the patient's history of hypertension, flame-shaped hemorrhages are a highly consistent finding.</li>\n<li><strong>Characteristics of Flame-Shaped Hemorrhages:</strong>\n<ul>\n<li><strong>Appearance:</strong> Diffuse, elongated red streaks.</li>\n<li><strong>Location:</strong> Found in the posterior pole.</li>\n<li><strong>Duration:</strong> Last approximately 6 to 12 weeks.</li>\n<li><strong>Origin:</strong> Occur in the <strong>superficial retinal capillary plexus</strong>, specifically in the ganglion nerve fiber layer.</li>\n<li><strong>Associations:</strong> Typically associated with <strong>arterial diseases like hypertension</strong>, as well as blood dyscrasias and anemias. They are also linked to venous stasis.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Dot-blot hemorrhage (Option B):</strong> Dot-blot hemorrhages tend to occur deeper in the retina, where the cells run vertically. They are more typically associated with background diabetic retinopathy. While the patient has diabetes, the morphology of the prominent hemorrhages in the image aligns more with flame-shaped.</p>\n<p><strong>Cotton wool spot (Option C):</strong> Cotton wool spots appear as fluffy, white patches on the retina, representing microinfarcts in the nerve fiber layer. While both hypertension and diabetes can cause cotton wool spots, the most prominent lesions in the image are clearly red hemorrhages, not white patches.</p>\n<p><strong>Microaneurysm (Option D):</strong> Microaneurysms appear as small, red dots, often indistinguishable from dot hemorrhages without fluorescein angiography. While common in diabetic retinopathy, the prominent lesions in the image are larger, linear hemorrhages, not tiny dots.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Flame-shaped hemorrhages</strong> are characteristic superficial retinal hemorrhages commonly associated with <strong>hypertension</strong> and other conditions affecting the superficial retinal capillary plexus.</li>\n<li><strong>Dot-blot hemorrhages</strong> are deeper and typically associated with diabetic retinopathy.</li>\n<li>The fundus image, combined with the patient's history of hypertension, strongly points to flame-shaped hemorrhages as the named lesion.</li>\n</ul>",
      "correct_choice_id": 251,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}